Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3).
Reich K, Leonardi C, Lebwohl M, Kerdel F, Okubo Y, Romiti R, Goldblum O, Dennehy EB, Kerr L, Sofen H. Reich K, et al. Among authors: dennehy eb. J Dermatolog Treat. 2017 Jun;28(4):282-287. doi: 10.1080/09546634.2016.1249820. Epub 2016 Nov 13. J Dermatolog Treat. 2017. PMID: 27759463 Free article. Clinical Trial.
Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3).
Menter A, Warren RB, Langley RG, Merola JF, Kerr LN, Dennehy EB, Shrom D, Amato D, Okubo Y, Reich K. Menter A, et al. Among authors: dennehy eb. J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1686-1692. doi: 10.1111/jdv.14237. Epub 2017 Apr 26. J Eur Acad Dermatol Venereol. 2017. PMID: 28322474 Clinical Trial.
Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe pain.
Peres MFP, Vasudeva R, Baygani SK, Dennehy EB, Vincent M, Friedman DI. Peres MFP, et al. Among authors: dennehy eb. Curr Med Res Opin. 2021 Jun;37(6):1031-1038. doi: 10.1080/03007995.2021.1903846. Epub 2021 Apr 7. Curr Med Res Opin. 2021. PMID: 33784930 Free article. Clinical Trial.
Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials.
Shapiro RE, Hochstetler HM, Dennehy EB, Khanna R, Doty EG, Berg PH, Starling AJ. Shapiro RE, et al. Among authors: dennehy eb. J Headache Pain. 2019 Aug 29;20(1):90. doi: 10.1186/s10194-019-1044-6. J Headache Pain. 2019. PMID: 31464581 Free PMC article. Clinical Trial.
Migraine history and response to lasmiditan across racial and ethnic groups.
Charleston L 4th, Savage-Edwards B, Bragg SM, Baygani SK, Dennehy EB. Charleston L 4th, et al. Among authors: dennehy eb. Curr Med Res Opin. 2022 May;38(5):721-730. doi: 10.1080/03007995.2022.2057152. Epub 2022 Apr 3. Curr Med Res Opin. 2022. PMID: 35350937 Free article. Clinical Trial.
63 results